tirzepatide hydration effects 2025 of on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial hydration effects tirzepatide weight loss

With retatrutide approaching ~30% weight loss at 2 yearsbut with what appears to be a meaningfully higher adverse event burden than earlier-generation incretin therapiesexpert clinical guidance will matter even more

It is always more evident in thin faces that have seen significant weight loss, since in overweight or obese patients, weight loss does not usually result in significant facial skeletonization

Press down on the dose knob until it stops, hold it down and count to 5 slowly

Its prescribed when individualized dosing or ingredient adjustments are clinically appropriate and not otherwise available in approved commercial products

Improvements in symptoms and quality of life at 4 years were still present at 12 years

[Crossref] Danan G, Teschke R (2015) RUCAM in drug and herb induced liver injury: The update